A Clinical Research Studying a Method of Intervention for Children Diagnosed With Anxiety Disorder: Attentional Bias Intervention
NCT ID: NCT00482820
Last Updated: 2013-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2007-07-31
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Two sets of predictions will be tested, one set concerns the effects of training on attention, and the other concerns the effects of training on anxiety. In terms of training effects on attention, we hypothesize that children with anxiety disorders can be trained to either avoid threat or attend to positive stimuli. In terms of training effects on anxiety symptoms, we hypothesize that the experimental training sessions will produce greater reduction in symptoms of anxiety than the placebo-control training sessions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Attention Bias Modification for Anxiety: A Randomized Control Trial With Biomarkers
NCT02200003
Attention Bias Modification Treatment (ABMT) for Anxiety Disorders in Youth
NCT02460536
Attention Bias Modification Treatment for Children With Social Anxiety
NCT01397032
Attention Bias Modification Treatment (ABMT) for Anxiety Disorders in Youth Who do Not Respond to CBT
NCT02272959
Attention Bias Modification Treatment for Anxious Youth
NCT01979263
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
attention training away from threat
attention-bias training
one group recive an attention training away from threat. The second group, the controll group, recive a placebo training
2
placebo attention training
attention-bias training
one group recive an attention training away from threat. The second group, the controll group, recive a placebo training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
attention-bias training
one group recive an attention training away from threat. The second group, the controll group, recive a placebo training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
7 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rabin Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
alan apter
Director, Feinberg Child Study Center and Department of Psychiatry, Schneider's Children's Medical Center of Israel
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bar-Haim Yair, Phd
Role: STUDY_DIRECTOR
Tel-aviv university; and schnider children's medical center of isreal
References
Explore related publications, articles, or registry entries linked to this study.
Eldar S, Apter A, Lotan D, Edgar KP, Naim R, Fox NA, Pine DS, Bar-Haim Y. Attention bias modification treatment for pediatric anxiety disorders: a randomized controlled trial. Am J Psychiatry. 2012 Feb;169(2):213-20. doi: 10.1176/appi.ajp.2011.11060886.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4373
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.